ReviewTranslational lung cancer research2019
Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition).
Review in Translational lung cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Consensus clustering based on CT radiomics has potential for risk stratification of patients with clinical T1 stage lung adenocarcinoma.BMC medical imaging · 2025Article
- [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022Review
- Pharmacokinetics, tissue distribution, and antitumor activity of a novel compound, NY-2, in non-small cell lung cancer.Frontiers in pharmacology · 2022Article
- Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients.Frontiers in oncology · 2022Article
- Postoperative adjuvant EGFR-TKIs for resectedAnnals of translational medicine · 2021Article
- Article
- Endothelial growth factor receptor-mutant lung cancer and post-operative care management: one size does not fit all.Annals of translational medicine · 2020Article
- Optimizing adjuvant therapy inAnnals of translational medicine · 2020Article
- Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?Translational lung cancer research · 2020Article
- EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?Translational lung cancer research · 2020Article
- Adjuvant TKI therapy in resectedTranslational lung cancer research · 2020Article
- EGFR and non-small cell lung cancer: implications for surgical practice.Annals of translational medicine · 2020Article
- Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!Annals of translational medicine · 2020Article
- Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer.Annals of translational medicine · 2020Article
- It takes all sorts to make a world: geographical differences and the future perspective of molecular testing in non-small cell lung cancer.Journal of thoracic disease · 2020Article
- Use of adjuvant EGFR tyrosine kinase inhibitors in early stageJournal of thoracic disease · 2020Article
- One step too far in the right direction: The Society for Translational Medicine 2019 consensus on postoperative management of EGFR-mutant lung cancer.Journal of thoracic disease · 2020Article
- Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way.Annals of translational medicine · 2020Article
- The adjuvant regimen for resected EGFR mutated patients: the "same-for-all-therapy" or not?Annals of translational medicine · 2020Article
- Postoperative management for non-small cell lung cancer harboringJournal of thoracic disease · 2020Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
60 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.